| Literature DB >> 29706454 |
Xinxin Peng1, Xiaoyan Xu2, Yumeng Wang3, David H Hawke4, Shuangxing Yu5, Leng Han6, Zhicheng Zhou7, Kamalika Mojumdar1, Kang Jin Jeong5, Marilyne Labrie5, Yiu Huen Tsang8, Minying Zhang9, Yiling Lu5, Patrick Hwu10, Kenneth L Scott8, Han Liang11, Gordon B Mills5.
Abstract
Adenosine (A) to inosine (I) RNA editing introduces many nucleotide changes in cancer transcriptomes. However, due to the complexity of post-transcriptional regulation, the contribution of RNA editing to proteomic diversity in human cancers remains unclear. Here, we performed an integrated analysis of TCGA genomic data and CPTAC proteomic data. Despite limited site diversity, we demonstrate that A-to-I RNA editing contributes to proteomic diversity in breast cancer through changes in amino acid sequences. We validate the presence of editing events at both RNA and protein levels. The edited COPA protein increases proliferation, migration, and invasion of cancer cells in vitro. Our study suggests an important contribution of A-to-I RNA editing to protein diversity in cancer and highlights its translational potential.Entities:
Keywords: ADAR enzyme; CPTAC; RNA editing; RNA-seq; TCGA; amino acid changes; biomarker; cancer drivers; mass spectrometry data; somatic mutations
Mesh:
Substances:
Year: 2018 PMID: 29706454 PMCID: PMC5953833 DOI: 10.1016/j.ccell.2018.03.026
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743